SDC Stock Recent News
SDC LATEST HEADLINES
SmileDirectClub Inc. said late Friday it was winding down operations, effective immediately, seeming to cast its millions of customers adrift — except when it comes to their bills.
In business, as in life, there are no guarantees of success. And to put a twist on an observation by poet Robert Burns, the best laid plans of digital, app-driven platforms looking to upend the way things have always been done … can go astray.
Another once-prominent company has filed for bankruptcy. SmileDirectClub (NASDAQ: SDC ) rose to prominence as an innovator in the teledentistry field.
SmileDirectClub (NASDAQ: SDC ) stock is taking a beating on Tuesday as the company's shares continue to fall on a bankruptcy filing. SmileDirectClub announced the bankruptcy yesterday and said it's undergoing this action to enact a recapitalization transaction.
The sudden and unexpected bankruptcy filing by SmileDirectClub — the controversial tele-dentistry company — has some investors likely hoping it will make a comeback and survive through an acquisition.
SmileDirectClub (NASDAQ: SDC ) stock is a hot topic among traders after the online orthodontics company filed for bankruptcy. With that filing comes a reignited interest from investors who may be looking to short squeeze the stock.
SmileDirectClub (NASDAQ: SDC ) stock crashed nearly 60% overnight as the online orthodontics company filed for Chapter 11 bankruptcy. The stock opened at just 18 cents per share, a market capitalization of under $100 million.
SmileDirectClub (NASDAQ: SDC ) stock is falling hard on Monday after the oral care company filed for Chapter 11 bankruptcy. A press release from SmileDirectClub reveals that it has filed for Chapter 11 bankruptcy in order to effect a recapitalization transaction.
SmileDirectClub Inc (NASDAQ:SDC) stock starts the week plummeting around 60% after Friday's filing for voluntary chapter 11 bankruptcy protection, as the online subscription dental products firm seeks a recapitalization. The loss-making maker of silicon teeth aligners and teeth whitening kits traded down to 17 cents per share.
Syndax Pharmaceuticals Inc. SNDX, -7.10% rose 19% in premarket trading. The clinical stage biopharmaceutical company said late Friday that it would release topline results from its trial of Revumenib to treat certain forms of leukemia.